In re Lipitor Antitrust Litig.
| Decision Date | 21 August 2017 |
| Docket Number | 15-1187,14-4206,& 14-4602,15-1274,Nos. 15-1184,14-4203,15-1323 & 15-1342,14-4205,14-4204,15-1186,15-1185,Nos. 14-4202,s. 14-4202,s. 15-1184 |
| Citation | 868 F.3d 231 |
| Parties | IN RE: LIPITOR ANTITRUST LITIGATION Rite Aid Corporation; Rite Aid Hdqtrs Corporation; JCG (PJC) USA, LLC ; Maxi Drug, Inc. d/b/a Brooks Pharmacy; Eckerd Corporation, Appellants in No. 14-4202 Walgreen Company; The Kroger Company; Safeway, Inc.; Supervalu, Inc.; HEB Grocery Company L.P., Appellants in No. 14-4203 Giant Eagle, Inc., Appellant in No. 14-4204 Meijer Inc.; Meijer Distribution, Inc., Appellants in No. 14-4205 Rochester Drug Co-Operative, Inc. ; Stephen L. Lafrance Pharmacy, Inc. d/b/a Saj Distributors; Burlington Drug Company, Inc. ; Value Drug Company; Professional Drug Company, Inc. ; American Sales Company LLC, Appellants in No. 14-4206 A.F.L.-A.G.C. Building Trades Welfare Plan; Mayor and City Council of Baltimore, Maryland; New Mexico United Food and Commercial Workers Union's and Employers' Health and Welfare Trust Fund; Louisiana Health Service Indemnity Company, d/b/a Blue Cross/Blue Shield of Louisiana; Bakers Local 433Health Fund ; Twin Cities Bakery Workers Health and Welfare Fund; Fraternal Order of Police, Fort Lauderdale Lodge 31, Insurance Trust Fund; International Brotherhood of Electrical Workers Local 98; New York Hotel Trades Counsel & Hotel Association of New York City, Inc., Health Benefits Fund; Edward Czarnecki ; Emilie Heinle; Frank Palter; Andrew Livezey; Edward Ellenson; Jean Ellyne Dougan; Nancy Billington, On Behalf of Themselves and All Others Similarly Situated, Appellants in No. 14-4602 In re: Effexor XR Antitrust Litigation Walgreen, Co.; The Kroger, Co.; Safeway, Inc.; Supervalu, Inc.; HEB Grocery Company LP; American Sales Company, Inc., Appellants in No. 15-1184 Rite Aid Corporation; Rite Aid Hdqtrs., Corporation; JCG (PJC) USA, LLC ; Maxi Drug, Inc. d/b/a Brooks Pharmacy; Eckerd Corporation; CVS Caremark Corporation, Appellants in No. 15-1185 Giant Eagle, Inc., Appellant in No. 15-1186 Meijer, Inc.; Meijer Distribution, Inc., Appellants in No. 15-1187 Professional Drug Company, Inc. ; Rochester Drug Co-Operative, Inc. ; Stephen L. Lafrance Holdings, Inc.; Stephen L. Lafrance Pharmacy, Inc. d/b/a Saj Distributors; Uniondale Chemist, Inc., Appellants in No. 15-1274 Painters District Council No. 30 Health & Welfare Fund ; Medical Mutual of Ohio, Appellants in No. 15-1323 A.F. of L.-A.G.C. Building Trades Welfare Plan; Daryl Deino; IBEW-NECA Local 505 Health & Welfare Plan ; Louisiana Health Service Indemnity Company d/b/a Blue Cross/Blue Shield of Louisiana; Man-U Service Contract Trust Fund ; MC-UA Local 119 Health & Welfare Plan ; New Mexico United Food and Commercial Workers Union's and Employers' Health and Welfare Trust Fund; Plumbers and Pipefitters Local 572 Health and Welfare Fund; Sergeants Benevolent Association Health and Welfare Fund; Patricia Sutter (Together "End-payor Class Plaintiffs") on Behalf of Themselves and All Others Similarly Situated, Appellants in No. 15-1342 |
| Court | U.S. Court of Appeals — Third Circuit |
Monica L. Kiley, Hangley Aronchick Segal Pudlin & Schiller, 4400 Deer Path Road, Suite 200, Harrisburg, PA 17110, Maureen S. Lawrence, Barry L. Refsin [ARGUED], Hangley Aronchick Segal Pudlin & Schiller, One Logan Square, 18th & Cherry Streets, 27th Floor, Philadelphia, PA 19103, Counsel for Appellants Rite Aid Corp., Rite Aid Hdqtrs. Corp., Maxi Drug Inc., Eckerd Corp. and JCG (PJC) USA LLC.
Anna T. Neill, Scott E. Perwin [ARGUED], Lauren C. Ravkind, Kenny Nachwalter, P.A., 1441 Brickell Avenue, Four Seasons Tower, Suite 1100, Miami, FL 33131, Counsel for Appellants Walgreen Co., Kroger Co., Safeway Inc., Supervalu, Inc., HEB Grocery Co. LP and American Sales Co. LLC.
David P. Germaine, Joseph M. Vanek, Vanek, Vickers & Masini, P.C., 55 West Monroe Street, Suite 3500, Chicago, IL 60603, Moira Cain-Mannix, Bernard D. Marcus, Erin G. Allen, Marcus & Shapira LLP, One Oxford Centre, 35th Floor, Pittsburgh, PA 15219, Counsel for Appellant Giant Eagle, Inc.
Bradley J. Demuth, Linda P. Nussbaum, Nussbaum Law Group P.C., 570 Lexington Avenue, 19th Floor, New York, NY 10022, David P. Germaine, Joseph M. Vanek, Vanek Vickers & Masini, 55 West Monroe Street, Suire 3500, Chicago, IL 60603, Counsel for Appellants Meijer, Inc. and Meijer Distribution.
Gregory T. Arnold, Kristen A. Johnson, Kristie A. LaSalle, Thomas M. Sobol [ARGUED], Hagens Berman Sobol & Shapiro LLP, 55 Cambridge Parkway, Suite 301, Cambridge, MA 02142, Caitlin Coslett, Eric L. Cramer, Jennifer MacNaughton, Daniel Simons, David F. Sorensen [ARGUED], Richard D. Schwartz, Berger & Montague, P.C., 1622 Locust Street, Philadelphia, PA 19103, Elena K. Chan, Bruce E. Gerstein [ARGUED], Kimberly Hennings, Garwin Gerstein & Fisher LLP, 88 Pine Street, 10th Floor, New York, NY 10005, Peter Kohn, Richard D. Schwartz, Faruqi & Faruqi LLP, 101 Greenwood Avenue, Suite 600, Jenkintown, PA 19046, Miles Greaves, Barry S. Taus, Taus Cebulash & Landau, LLP, 80 Maiden Lane, Suite 1204, New York, NY 10038, Erin C. Burns, Dianne M. Nast, NastLaw LLC, 1101 Market Street, Suite 2801, Philadelphia, PA 19107, Don Barrett, Barrett Law Group, 404 Court Square, P.O. Box 927, Lexington, MS 39095, Counsel for Appellants Direct-Purchaser Class Plaintiffs Rochester Drug Co-Operative, Inc., et al.
James E. Cecchi [ARGUED], Lindsey H. Taylor, Carella, Byrne, Cecchi, Olstein, Brody, & Agnello, P.C., 5 Becker Farm Road, Roseland, NJ 07068, Peter S. Pearlman, Cohn Lifland Pearlman Herrmann & Knopf LLP, Park 80 West—Plaza One, 250 Pehle Avenue, Suite 401, Saddle Brook, NJ 07663, Liaison Counsel for Appellants Direct-Purchaser Class Plaintiffs Rochester Drug Co-Operative, Inc., et al.
Justin N. Boley, Bethany R. Turke, Kenneth A. Wexler, Wexler Wallace LLP, 55 West Monroe Street, Suite 3300, Chicago, IL 60603, James W. Anderson, Vincent J. Esades, Renae Steiner, David R. Woodward [ARGUED], Heins Mills & Olson, P.L.C., 310 Clifton Avenue, Minneapolis, MN 55403, J. Douglas Richards, Sharon K. Robertson, Cohen Milstein Sellers & Toll, PLLC, 88 Pine Street, 14th floor, New York, NY 10005, Michael M. Buchman, Alex Straus, Esq., Motley Rice LLC, 600 Third Avenue, Suite 2101, New York, NY 10016, Jeffrey L. Kodroff, John A. Macoretta, Spector Roseman Kodroff & Willis, 181 Market Street, Suite 2500, Philadelphia, PA 19103, Counsel for Appellants End-Payor Class Plaintiffs AFL-AGC Building Trades Welfare Plan, et al.
Lisa J. Rodriguez, Schnader Harrison Segal & Lewis LLP, Woodland Falls Corporate Park, 220 Lake Drive East, Suite 200, Cherry Hill, NJ 08002-1165, Liaison Counsel for Appellants End-Payor Class Plaintiffs AFL-AGC Building Trades Welfare Plan, et al.
Joseph M. Alioto, Jamie L. Miller, Theresa Driscoll Moore, Alioto Law Firm, One Sansome Street, 35th Floor, San Francisco, CA 94104, Timothy A.C. May, Gil D. Messina, Messina Law Firm, P.C., 961 Holmdel Road, Holmdel, NJ 07733, Lori A. Fanning, Marvin A. Miller, Matthew E. Van Tine, Miller Law LLC, 115 South LaSalle Street, Suite 2910, Chicago, IL 60603, Kevin P. Roddy, Wilentz, Goldman & Spitzer, P.A., 90 Woodbridge Center Drive, Suite 900, Woodbridge, NJ 07095, Mark S. Sandmann, Hill Carter Franco Cole & Black, P.C., 99102 Brinley Avenue, Suite 201, Louisville, KY 40243, Counsel for Appellants Painters District Council No. 30 Health & Welfare Fund and Medical Mutual of Ohio
Steve D. Shadowen, Hilliard & Shadowen LLP, 919 Congress Avenue, Suite 1325, Austin, TX 78701, Michael A. Carrier, Rutgers Law School, 217 North Fifth Street, Camden, NJ 08102, Counsel for 48 Law, Economics, and Business Professors and the American Antitrust Institute as Amici Curiae in support of Appellants
Jonathan E. Nuechterlein, Former General Counsel
David C. Shonka, Acting General Counsel
Joel Marcus, Director of Litigation
Michele Arington, Assistant General Counsel
Deborah L. Feinstein, Director
Markus H. Meier, Acting Deputy Director
Bradley S. Albert, Deputy Assistant Director
Elizabeth R. Hilder, Heather Johnson, Jamie R. Towey, Federal Trade Commission, 600 Pennsylvania Avenue, N.W., Washington, DC 20580, Counsel for Federal Trade Commission as Amicus Curiae in support of Appellants
Dimitrios T. Drivas, Raj S. Gandesha, Bryan D. Gant, Sheryn E. George, Robert A. Milne [ARGUED], Brendan G. Woodard, Amy E. Boddorff, White & Case LLP, 1155 Avenue of the Americas, New York, NY 10036, Liza M. Walsh, Eleonore Ofosu-Antwi, Walsh Pizzi O'Reilly & Falanga, One Riverfront Plaza, 1037 Raymond Boulevard, 6th Floor, Newark, NJ 07102, Counsel for Appellees Pfizer, Inc., Pfizer Ireland Pharmaceuticals, Warner–Lambert Company, Warner-Lambert Company LLC, Wyeth, Inc., Wyeth Pharmaceuticals, Inc., Wyeth-Whitehall Pharmaceuticals LLC and Wyeth Pharmaceuticals Company
Jonathan D. Janow, John C. O'Quinn, Gregory L. Skidmore, Edwin J. U, Karen N. Walker, Kirkland & Ellis LLP, 655 15th Street, N.W., Suite 1200, Washington, DC 20005, Jay P. Lefkowitz, [ARGUED], Joseph Serino, Jr., Steven J. Menashi, Kirkland & Ellis LLP, 601 Lexington Avenue, New York, NY 10022, Counsel for Appellees Ranbaxy, Inc., Ranbaxy Pharmaceuticals, Inc., Ranbaxy Laboratories Ltd., Teva Pharmaceutical Industries Ltd. and Teva Pharmaceuticals USA, Inc.Katherine A. Helm, Noah M. Leibowitz, Simpson Thacher & Bartlett LLP, 425 Lexington Avenue, New York, NY 10017, Victor E. Schwartz, Philip S. Goldberg, Cary Silverman, Shook, Hardy & Bacon L.L.P., 1155 F Street NW, Suite 200, Washington, DC 20004, Counsel for American Tort Reform Association and Pharmaceutical Research and Manufacturers of America as Amici Curiae in support of Appellees
Jonathan D. Hacker, Edward Hassi, O'Melveny & Myers LLP, 1625 Eye Street NW, Washington, DC 20006, Counsel for Antitrust Economists as Amici Curiae in support of Appellees
Ashley Bass, Stephen Bartenstein, Andrew D. Lazerow, Covington & Burling LLP, 850 10th Street, N.W., One City Center, Washington, D.C. 20001, Counsel for Pharmaceutical Research and Manufacturers of America as ...
To continue reading
Request your trial
-
In re Xyrem (Sodium Oxybate) Antitrust Litig.
... ... Moreover, trial on Xyrem's 555 F.Supp.3d 854 remaining patents was "weeks away." CAC 209. Thus, Hikma could either launch (A) after potentially prevailing at trial; or (B) before a final litigation outcome. See generally, e.g., In re Lipitor Antitrust Litig. , 868 F.3d 231, 241 (3d Cir. 2017) (describing generic manufacturer's option to launch "at risk" during ongoing litigation). Either way, Hikma's "manufacture, market[ing], and s[ale] of an AB-rated generic version of Xyrem" did not seem far off. CAC 126. An alleged chain of ... ...
-
In re Epipen
... ... F.Supp.3d 922 IN RE: EPIPEN (EPINEPHRINE INJECTION, USP) MARKETING, SALES PRACTICES AND ANTITRUST LITIGATION (This Document Applies to Consumer Class Cases) MDL No: 2785 Case No. 17-md-2785-DDC-TJJ ... See Transfer Order at Schedule A, In re: Armodafinil Patent Litig. , No. 1:10-md-02200 (D. Del. Dec. 8, 2010), ECF No. 1. In December 2010, the Judicial Panel on ... See, e.g. , In re Lipitor Antitrust Litig. , 868 F.3d 231, 258 (3d Cir. 2017) (holding that settlement agreement was ... ...
-
Fed. Trade Comm'n v. Abbvie Inc.
... ... & Shadowen, 1135 West 6th Street, Suite 125, Austin, TX 78703, Attorney for Amici American Antitrust Institute, Public Citizen Inc, and Public Knowledge Before: HARDIMAN, PORTER and PHIPPS, Circuit ... " associated with it is "long, comprehensive, and costly." In re Wellbutrin XL Antitrust Litig. Indirect Purchaser Class , 868 F.3d 132, 143 (3d Cir. 2017) (citation omitted). It includes "full ... antitrust law, not federal patent law, creates [the FTC's] claims." In re Lipitor Antitrust Litig. , 855 F.3d 126, 145 (3d Cir. 2017) (emphasis omitted). So "[t]his case ... turns ... ...
-
In re Humira (Adalimumab) Antitrust Litig.
... ... Teikoku Pharma USA, Inc. , 74 F.Supp.3d 1052, 106768 (N.D. Cal. 2014) (recognizing that agreements that increase competition fall outside the scope of Actavis ). 18 In both King Drug, and In re Lipitor Antitrust Litig. , the Third Circuit acknowledged 465 F.Supp.3d 842 that it might not be appropriate to justify anticompetitive effects in one market with procompetitive effects in another. King Drug , 791 F.3d at 409 n.34 ; In re Lipitor Antitrust Litig. , 868 F.3d 231, 256 n.12 (3d Cir ... ...
-
Antitrust Issues Involving Intellectual Property
...on judicial determinations in prior litigation and (2) the PTO’s reissuance of the patent was improper. In re Lipitor Antitrust Litig., 868 F.3d 231, 267-71 (3d Cir. 2017). 67. 141 F.3d 1059, 1068 (Fed. Cir. 1998). 68. Id. at 1068. Nobelpharma expressly overruled the Federal Circuit’s prior......
-
What encompasses petitioning?
...antitrust scrutiny. 146 A number of other courts have similarly held that 141. Id. 142. 263 F.3d 239 (3d Cir. 2001). 143. Id. at 239. 144. 868 F.3d 231 (3d Cir. 2017). 145. Id . at 264. 146. Id . at 265. The court also noted that accepting defendants’ argument “would have the practical effe......
-
Regulated Industries
...litigants a viable path to resolve their disputes.”), rev’d , 814 F.3d 538, 549 (1st Cir. 2016). 1307. See In re Lipitor Antitrust Litig., 868 F.3d 231, 252 (3rd Cir. 2017) (holding that an agreement to release claims in a suit with large expected damages and a high likelihood of success wa......
-
Antitrust Exemptions And Immunities
...approved a private settlement agreement that later becomes subject to antitrust scrutiny. For example, in In re Lipitor Antitrust Litig. , 868 F.3d 231 (3d. Cir. 2017), the Third Circuit clarified that Noerr-Pennington does not apply simply because the courts and the government have approve......